HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 11 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $32,805,000 | +8.5% | 17,444,000 | 0.0% | 0.04% | +35.7% |
| Q1 2022 | $30,242,000 | -0.5% | 17,444,000 | 0.0% | 0.03% | +12.0% |
| Q4 2021 | $30,383,000 | +153.4% | 17,444,000 | +158.8% | 0.02% | +127.3% |
| Q3 2021 | $11,988,000 | +53.2% | 6,741,000 | +68.5% | 0.01% | +57.1% |
| Q2 2021 | $7,824,000 | – | 4,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 33,098,000 | $57,663,000 | 0.54% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,750,000 | $22,298,000 | 0.47% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $3,522,000 | 0.07% |
| Calamos Advisors LLC | 10,000,000 | $17,559,000 | 0.07% |
| Hudson Bay Capital Management LP | 3,500,000 | $6,138,000 | 0.06% |
| D. E. Shaw & Co., Inc. | 17,444,000 | $30,383,000 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 3,752,000 | $6,588,286,000 | 0.01% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 115,000 | $203,000 | 0.00% |
| JPMORGAN CHASE & CO | 3,316,000 | $5,854,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,686,000 | $6,414,000 | 0.00% |